Treatments

The plans include the acquisition of more than 170 million doses of the new boosters, which will be available to consumers without an out-of-pocket cost.

...

Country / Region Tags:

United States

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about New booster:
Log in or register to post comments

U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine

Thu, 2022-09-08 17:31 — mike kraft

U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine

Reuters--

...

U.S. health regulators last month authorized injecting the shot intradermally in adults, meaning between layers of the skin rather than below the skin, in an effort to stretch out low vaccine supplies. read more

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine
Log in or register to post comments

Omicron variant BA.4.6 evades protection of Evusheld's antibodies, study finds

Thu, 2022-09-08 17:23 — mike kraft

New Omicron offshoot BA.4.6 evades protection of Evusheld's antibodies, study finds The antibodies in Evusheld, the only therapy available to protect people with reduced immune function against Covid-19, may lose their punch against the BA.4.6 subvariant, a new study shows. Brenda Goodman, CNN CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Omicron variant BA.4.6 evades protection of Evusheld's antibodies, study finds
Log in or register to post comments

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies; Donates Paxlovid to poorer countries i

Wed, 2022-09-07 16:29 — mike kraft

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies Researchers studying next-gen vaccines to fight an evolving Covid threat are running into problems getting existing vaccines to use in their research. Rachel Cohrs STAT

WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems getting existing vaccines to use in their research.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Nasel spray vaccines might stop the coronavirus in its tracks, although there’s little evidence from human trials so far.

Wed, 2022-09-07 16:18 — mike kraft

China and India approve nasal COVID vaccines — are they a game changer? Nature - Scientists hope the immunizations, delivered through the nose or mouth, will prevent even mild cases of illness. Waltz, Emily nature

...

These mucosal vaccines target thin mucous membranes that line the nose, mouth and lungs. By prompting immune responses where SARS-CoV-2 first enters the body, mucosal vaccines could, in theory, prevent even mild cases of illness and block transmission to other people — something COVID-19 shots have been unable to do. Vaccines that produce sterilizing immunity would be game changing for the pandemic. ...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Israel reports it has isolated a coronavirus antibody in 'significant breakthrough

Wed, 2022-09-07 16:09 — mike kraft

Two antibodies identified in Israel can fight all known COVID strains, study finds Infusible to patients, antibodies are so powerful neutralizing the coronavirus they could eliminate the need for more vaccine boosters, peer-reviewed research says timesofisrael

...

The antibody reported as having been isolated at the IIBR is monoclonal, meaning it was derived from a single recovered cell and is thus potentially of more potent value in yielding a treatment.

...

Country / Region Tags:

General Topic Tags: